Vpriv
Payments companies reported to CMS as associated with Vpriv. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vpriv, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vpriv
These are the largest totals companies reported as associated with Vpriv. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Stockton | Detroit, MI | Internal Medicine | $9,614.73 |
| Alberto Santiago Cornier | Santurce, PR | Clinical Genetics (M.D.) | $6,939.24 |
| Linda Spencer | Troy, MI | Nurse Practitioner | $5,640.12 |
| John Jefferies | Memphis, TN | Advanced Heart Failure and Transplant Cardiology | $3,501.75 |
| Gregory Grabowski | Cincinnati, OH | Clinical Genetics (M.D.) | $2,789.45 |
| Ozlem Goker-Alpan | Fairfax, VA | Pediatrics | $583.87 |
| Wendy Chung | Boston, MA | Clinical Genetics (M.D.) | $510.00 |
| Ahuva Lamm | Monsey, NY | Medical | $395.18 |
| Esther Bekritsky | Monsey, NY | Pediatrics | $327.36 |
| Kyi Yu | Rockaway Beach, NY | Family Medicine | $277.56 |
Prescribed Vpriv?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.